Home
|
MedWorm: CialisTadalafil Doesn't Worsen Bladder Function in Benign Prostatic Hyperplasia Treatment with tadalafil for lower urinary tract symptoms in men with benign prostatic hyperplasia does not impair their bladder function, researchers report in the March issue of the Journal of Urology. Reuters Health Information (Source: Medscape Medical News Headlines) MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. The Irish Medicines Board warned consumers not to buy or use this product because it contains undeclared Tadalafil. Tadalafil is a prescription drug and should only be taken under the supervision of a health care practitioner. (Source: Government of Canada News - Health Canada) The Hong Kong Department of Health warned consumers not to buy or use this product because it contains undeclared Tadalafil. Tadalafil is a prescription drug and should only be taken under the supervision of a health care practitioner. (Source: Government of Canada News - Health Canada) The Food and Drug Administration has issued a warning to Eli Lilly & Co. and United Therapeutics that a Web page and two patient videos were in violation of the agency's promotional rules. Adcirca (tadalafil) is indicated for pulmonary arterial hypertension to improve exercise ability. The FDA cited the Web page for failing to include any contraindications, warnings, or precautions for the drug, which “misleadingly suggests that Adcirca is safer than has been demonstrated,” said the warning letter. The two patient videos “seriously misrepresent what is known about the efficacy of Adcirca,” said the FDA. The agency directed the drug makers to immediately cease dissemination of the offending materials. (Source: Cardiology News) Cialis 2.5mg, 5mg, 10mg & 20mg film-coated tablets (tadalafil) - Revised SPC Source: eMC (electronic Medicines Compendium) Area: Other Library Updates > SPC Changes Change to section 4.8 - Undesirable Effects - Nervous system disorders: Stroke(including haemorrhagic events), Syncope, Transient ischaemic attacks, Migraine. (Source: NeLM - SPC Changes) CIALIS (Tadalafil) Tablet, Film Coated [Eli Lilly And Company] Updated Date: Feb 16, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)) MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. To present the methodology, standardization techniques, and results from post hoc test-retest reproducibility analyses for a large, placebo-controlled, multicenter trial, employing urodynamic studies (UDS) to assess the impact of daily tadalafil on men with lower urinary tract symptoms (LUTS) with or without benign prostatic obstruction (BPO).UDS implemented International Continence Society (ICS) Good Urodynamic Practice guidelines and standardized urodynamic and LUTS terminology. Further standardization procedures included: equipment calibration; a detailed procedure manual and centralized training; and implementation of a central reader. Measures included: monitoring of invalid studies, comparison of actual versus expected standard deviation (SD) for primary outcome (detrusor pressure at... What Do Men and Women Want? Ask the Superbowl Ads Human orcas performing for pretzels. Chickens scared to death of Denny's Grand Slam offers. That Dorito's kids who doesn't want to share his mom, or his Dorito's--and not necessarily in that order--with mom's new suitor.Yes, the Superbowl is the one time of the year we aren't grumbling about advertising as interruption, but looking to it for entertainment. And the advertising industry knows it, unveiling their riskiest, most expensive, and sometimes (they hope) funniest or most moving efforts for the occasion. Sometimes the ads are too hokey or even incomprehensible for words--remember the Cialis spot, with a man and woman holding hands outdoors in his and hers bathtubs?--but if they're talked about in the following days, then the agencies have done their job.Two ads this year really caugh... Purpose: We explored the impact of once daily tadalafil on urodynamic measures in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia via invasive and noninvasive urodynamic studies.Materials and Methods: We conducted a multicenter, randomized, double blind, placebo controlled clinical trial comparing once daily tadalafil 20 mg vs placebo during 12 weeks in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia with or without bladder outlet obstruction. Invasive and noninvasive urodynamics, International Prostate Symptom Score and general safety were assessed. The primary study end point was change in detrusor pressure at maximum urinary flow rate.Results: Urodynamic measures remained largely unchanged during the study... Conclusions: Coadministration of silodosin and maximum therapeutic doses of sildenafil or tadalafil in healthy men caused no clinically important orthostatic changes in blood pressure or HR and no orthostatic symptoms. (Source: Urology) Health News of the Day, part two Health News of the Day is a daily summary made from the selected links I post on Twitter. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce about 2,500 items per day: Vitamin nation - "Mediterranean diet does not come in a pill or potion. You have to eat the foods to reap the rewards" http://bit.ly/77P7TO Diagnosis and management of vitamin D deficiency - BMJ review, 2010 http://bit.ly/6yYT6d New ED drug avanafil is effective in just 15 minutes, far faster than blockbuster rivals Viagra and Cialis http://bit.ly/8g30uC 1,000 people a day - nearly half of them foreign holidaymakers - are injured in winter sports accidents in Switzerland http://bit.ly/5KAzOa More than 24 million Chinese men could find themselves without spouses i... MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. Preliminary study supports vascular benefit of PDE5 inhibition Administration of the phosphodiesterase type 5 inhibitor tadalafil citrate is associated with a reduction in oxidative stress and increased serum levels of paraoxonase-1, Turkish researchers have shown. (Source: MedWire News - Lipidology) Sudden Sensorineural Hearing Loss Associated with Vardenafil We describe a patient who developed unilateral sudden sensorineural hearing loss possibly related to the use of vardenafil for erectile dysfunction. To our knowledge, only one other case of hearing loss related to this drug class has been published. Our patient was a 57-year-old man who came to the emergency department with right-sided mild-to-moderate hearing loss in the 500-3000-Hz range, confirmed by audiogram, that occurred after ingestion of vardenafil. The patient was hospitalized 2 days later for administration of intravenous dexamethasone, followed by oral prednisone. He reported that his hearing had improved on the fourth hospital day and was discharged 3 days later, continuing to taper the prednisone on an outpatient basis. A repeat audiogram after 10 days of corticosteroid thera... Sexual Enhancement Products Recalled – contain sildenafil analogue The FDA announced this week that Atlas Operations has initiated a recall of their dietary supplements marketed for “male enhancement”. Analysis revealed that some of the products contained sulfoaildenafil, a sildenafil analogue. This drug has the potential to cause dangerous decreases in blood pressure, especially for patients taking certain other medications such as nitroglycerin. According to a press release from the company, some of the products recalled include Staminil, Love Fuel, Erexxx, Finally on Demand, and Whatzup. The take-home lesson for clinicians is that in addition to asking that middle-aged gentleman with chest pain if he takes Viagra, Cialis, or Levitra before giving nitroglycerine, it is important also to ask if he takes any natural or herbal or over-the... Therapeutic methods used in patients with Eisenmenger syndrome. Authors: Trojnarska O, Plaskota K Patients with Eisenmenger syndrome form a small percentage of congenital heart disease patients. The rarity of this syndrome, combined with its complex pathophysiology, account for the insufficient understanding of the principles underlying its proper treatment. The main clinical symptoms are: cyanosis due to secondary erythrocytosis, resulting in increased blood viscosity, iron deficiency anemia (enhanced by unnecessary phlebotomies), blood clotting disturbances, heart failure and serious supraventricular and ventricular arrhythmias. Recent decades have seen developments in pulmonary hypertension pathophysiology which have led to the introduction of new groups of drugs: prostacycline analogs (Epoprostenol, Treprostinil, Beraprost, Illoprost), phosphod... Non-congenital heart disease associated pediatric pulmonary arterial hypertension This article discusses the available knowledge regarding several disorders associated with pulmonary hypertension in children: idiopathic pulmonary arterial hypertension (IPAH), pulmonary capillary hemangiomatosis, pulmonary veno-occlusive disease, hemoglobinopathies, hepatopulmonary syndrome, portopulmonary hypertension and HIV. Three classes of drugs have been extensively studied for the treatment of IPAH in adults: prostanoids (epoprostenol, treprostinil, iloprost, beraprost), endothelin receptor antagonists (bosentan, sitaxsentan, ambrisentan), and phosphodiesterase inhibitors (sildenafil, tadalafil). These medications have been used in treatment of children with pulmonary arterial hypertension, although randomized clinical trial data is lacking. As pulmonary vasodilator therapy in cer... MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. Effects of 12-month tadalafil therapy for erectile dysfunction on couple relationships: Results ... Andrology Unit, Department of Urology, Antwerp University Hospital, Edegem, Antwerp, Belgium. (Source: UroToday) Erectile Dysfunction Treatment: Alternatives to Pills From the NYTimes:30 million men in U.S. experience erectile dysfunction (ED), 30% of men in their 50s, more than 50% of those in their 60s.One Viagra pill, the most common way to treat erection problems, costs about $15. Viagra, Cialis and Levitra do not work for about half of the men with ED.After 2 years of significant lifestyle changes (and no meds), 58% of the men with ED had normal erectile function.Self-administered injections of alprostadil for ED cost $35; a "cocktail" of alprostadil, papaverine, phentolamine.References:For Common Male Problem, Hope Beyond a Pill. NYTimes.Erectile Dysfunction Medications Related to Transient Amnesia, FDA WarnsImage source: Viagra (sildenafil), Wikipedia, GNU Free Documentation License. Posted at Clinical Cases and Images. Stay updated and subscr... Physicochemical characterization of solid dispersion systems of tadalafil with poloxamer 407. Authors: Vyas V, Sancheti P, Karekar P, Shah M, Pore Y Dissolution behaviour of a poorly water-soluble drug, tadalafil, from its solid dispersion systems with poloxamer 407 has been investigated. Solid dispersion systems of tadalafil were prepared with poloxamer 407 in 1:0.5, 1:1.5 and 1:2.5 ratios using the melting method. Characterization of binary systems with FTIR and XRPD studies demonstrated the presence of strong hydrogen bonding interactions, a significant decrease in crystallinity and the possibility of existence of amorphous entities of the drug. In the binary systems tested, 1:0.5 proportion of tadalafil/poloxamer 407 showed rapid dissolution of tadalafil (DE30 70.9 +/- 3.6 %). In contrast, higher proportions of poloxamer 407 (1:1.5 and 1:2.5) offered no advantage towards di... Phosphodiesterase Type 5 Inhibitors and Female Sexual Response: Faulty Protocols or Paradigms? Conclusions. The lack of efficacy of PDE5 treatment in women is likely attributable to gender differences in the concordance between physiological and psychological components of sexual response. Discordance between genital and subjective measures of sexual response in women may be augmented by PDE5 effects on genital vasocongestion in some populations, rendering successful treatment unlikely via pharmacological treatment alone. Chivers M, and Rosen RC. PDE5 inhibitors and female sexual response: Faulty protocols or paradigms? J Sex Med **;**:**[ndash]**. (Source: The Journal of Sexual Medicine) The drug sildenafil (Viagra, Pfizer) and, more recently, tadalafil (Cialis, Lilly-Icos) and vardenafil (Levitra, Bayer), has drawn public attention to aphrodisiacs. The search for such substances dates back millennia. Adverse effects associated with these ... (Source: SafetyLit: All (Unduplicated)) MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. Phosphodiesterase Type 5 Inhibitors for Pulmonary Arterial Hypertension A 46-year-old-woman presents with exertional dyspnea and syncope and receives a diagnosis of idiopathic pulmonary arterial hypertension. Treatment with sildenafil is recommended. Sildenafil and tadalafil are phosphodiesterase type 5 inhibitors that ameliorate pulmonary arterial hypertension by increasing levels of cyclic guanosine monophosphate in the smooth-muscle cells of the pulmonary artery. (Source: New England Journal of Medicine) Conclusion:Oral PDE-5 inhibitors improved erectile functioning and had similar efficacy and safety profiles. Results on the efficacy of hormonal treatments and the value of hormone testing in men with ED were inconclusive.Primary Funding Source:Agency for Healthcare Research and Quality. PMID: 19884626 [PubMed - as supplied by publisher] (Source: Annals of Internal Medicine) Authors: Qaseem A, Snow V, Denberg TD, Casey DE, Forciea MA, Owens DK, Shekelle P, Description:The American College of Physicians developed this guideline to present the available evidence on hormonal testing in and pharmacologic management of erectile dysfunction. Current pharmacologic therapies include phosphodiesterase-5 (PDE-5) inhibitors, such as sildenafil, vardenafil, tadalafil, mirodenafil, and udenafil, and hormonal treatment.Methods:Published literature on this topic was identified by using MEDLINE (1966 to May 2007), EMBASE (1980 to week 22 of 2007), Cochrane Central Register of Controlled Trials (second quarter of 2007), PsycINFO (1985 to June 2007), AMED (1985 to June 2007), and SCOPUS (2006). The literature search was updated by searching for articles in MEDLINE and EMBA... Phosphodiesterase-5 inhibitors: future perspectives. Authors: Konstantinos G, Petros P PDE-5 inhibitors were originally studied in cardiovascular indications but were later developed and approved for on-demand treatment of erectile dysfunction (ED). A few years ago sildenafil was approved for the treatment of pulmonary hypertension, thus renewing interest in cardiovascular applications, and tadalafil became available in once-daily formulations for erectile dysfunction management. Given the wide distribution of phosphodiesterase-5 throughout the body and its involvement in multiple functions, what can one expect in the future? To answer this we reviewed studies involving PDE-5 inhibitors that were published within the past three years and searched the US National Institutes of Health clinical trial registry for ongoing ones. PDE-5 inhibit... PDE5 Inhibitors in Non-Urological Conditions. Authors: Vlachopoulos C, Terentes-Printzios D, Ioakeimidis N, Rokkas K, Stefanadis C Phosphodiesterase type-5 (PDE5) inhibitors are widely used as first-line therapy for erectile dysfunction (ED). Their efficacy and safety combined with an increasing understanding of cyclic guanosine monophosphate (cGMP)-regulated mechanisms, have triggered a number of attempts to determine their effects and potential benefits in non-urological conditions. In recent years, extensive and diverse preclinical and clinical evidence has been made available. PDE5 inhibition has shown collateral benefits for a multitude of risk factors or diseases associated with, or accompanying ED. To date, PDE5 inhibition has been shown to be effective for the treatment of idiopathic pulmonary arterial hypertension and bot... MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. This article examines the peer-reviewed published data addressing patient's preference and adherence to ED treatment with PDE5 inhibitors. It also examines strategies to improve compliance and satisfaction with treatment. PMID: 19860694 [PubMed - in process] (Source: Current Pharmaceutical Design) Phosphodiesterase type 5 inhibitors: unmet needs. Authors: Hatzimouratidis K, Hatzichristou DG Erectile dysfunction (ED) has been revolutionized during the last two decades, as several treatment options are available today. Phosphodiesterase type 5 (PDE5) inhibitors (sildenafil, tadalafil, vardenafil) are currently the first choice treatment option for ED by most physicians and patients due to their high efficacy rates and favourable safety profiles. Despite the fact that more than 50 million ED patients have been treated successfully worldwide with PDE5i several issues remain to be addressed. Patients with severe neurologic damage, diabetes mellitus, or severe vascular disease may be resistant to PDE5i. Inappropriate instructions, lack of follow-up and lack of patient-centered care models have been identified as main reasons for "non... PDE5 Inhibitors: In Vitro and In Vivo Pharmacological Profile. Authors: Kouvelas D, Goulas A, Papazisis G, Sardeli C, Pourzitaki C PDE5 inhibitors have been clearly established as first-line therapy for the treatment of erectile dysfunction (ED). Three PDE5 inhibitors - sildenafil (Viagra((R))), vardenafil (Levitra((R))) and tadalafil (Cialis((R))) - are currently approved by the FDA and the EMEA for use in ED, whereas sildenafil is also marketed under a different proprietary name (Revatio((R))) for the treatment of pulmonary arterial hypertension (PAH). A forth PDE5 inhibitor, udenafil (Zydena((R))), is currently marketed. In the present review the molecular basis and the mechanism of action of PDE5 inhibitors is discussed. In addition experimental and clinical data concerning their effects on different tissues, organs and systems is systematical... How does tadalafil compare with placebo in treating erectile dysfunction? International Journal of Impotence Research (Source: Medscape Urology Headlines) European CHMP supports change of indication for tadalafil (Adcirca®) Source: EMEA Area: News The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, supporting the change of indication for tadalafil (Adcirca®) from erectile dysfunction (under name Tadalafil Lilly) to pulmonary arterial hypertension. (Source: NeLM - Urology) MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. Studies show Viagra, other drugs outperform hormone treatment The so-called PDE5 inhibitors are better at treating erectile dysfunction, according to a new guideline from the American College of Physicians. Just in case anyone out there was unconvinced that erectile dysfunction is best treated by popping one of those well-advertised pills, the American College of Physicians has officially proclaimed the superiority of drugs such as Viagra, Levitra and Cialis over hormone treatment. (Source: Los Angeles Times - Science) Conclusion Our study results showed that tadalafil has a vasodilatory effect on both acute and chronic periods of cerebral vasospasm. We also concluded that cerebral angiography can be used safely for investigation of cerebral vasospasm in animal studies. Content Type Journal ArticleCategory Experimental ResearchDOI 10.1007/s00701-009-0540-xAuthors Ender Koktekir, Ministry of Health Ankara Education and Research Hospital Neurosurgery Department Ankara TurkeyYavuz Erdem, Ministry of Health Ankara Education and Research Hospital Neurosurgery Department Ankara TurkeyMehmet Akif Bayar, Ministry of Health Ankara Education and Research Hospital Neurosurgery Department Ankara TurkeyCevdet Gokcek, Ministry of Health Ankara Education and Research Hospital Neurosurgery Departmen... Sexual Satisfaction in Men with Erectile Dysfunction: Correlates and Potential Predictors Introduction. Sexual satisfaction is an important treatment objective for men with erectile dysfunction (ED).Aims. To evaluate potential associations between International Index of Erectile Function (IIEF) satisfaction at study endpoint and a range of baseline, on-treatment, and endpoint variables.Methods. An exploratory analysis was conducted involving 3,935 subjects with ED randomized to on-demand tadalafil (N = 2,824) or placebo (N = 1,111) in randomized, controlled trials across 28 countries. Patients achieving scores [ge]16 on IIEF questions 7, 8, 13, and 14 at study endpoint were operationally defined as satisfied (vs. (Source: The Journal of Sexual Medicine) When Viagra fails: Study looking at stents to help with erectile dysfunction Medtronic Inc. is conducting a small study to see if using a stent to prop open arteries near the penis can help men with erectile dysfunction for whom drugs such as Pfizer Inc.'s Viagra and Eli Lilly & Co.'s Cialis don't work. The one-year study will... (Source: OrlandoSentinel: Medical Research) Vital Signs: Regimens: Doctors Group Endorses Erectile Drugs The American College of Physicians cited the lack of bad side effects in offering its support for medications like Viagra. (Source: NYT > Health) MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. Authors: Qaseem A, Snow V, Denberg TD, Casey DE, Forciea MA, Owens DK, Shekelle P, Description: The American College of Physicians developed this guideline to present the available evidence on hormonal testing in and pharmacologic management of erectile dysfunction. Current pharmacologic therapies include phosphodiesterase-5 (PDE-5) inhibitors, such as sildenafil, vardenafil, tadalafil, mirodenafil, and udenafil, and hormonal treatment. Methods: Published literature on this topic was identified by using MEDLINE (1966 to May 2007), EMBASE (1980 to week 22 of 2007), Cochrane Central Register of Controlled Trials (second quarter of 2007), PsycINFO (1985 to June 2007), AMED (1985 to June 2007), and SCOPUS (2006). The literature search was updated by searching for articles in MEDLINE and E... CONCLUSION: Oral PDE-5 inhibitors improved erectile functioning and had similar efficacy and safety profiles. Results on the efficacy of hormonal treatments and the value of hormone testing in men with ED were inconclusive. Primary Funding Source: Agency for Healthcare Research and Quality. PMID: 19843531 [PubMed - as supplied by publisher] (Source: Annals of Internal Medicine) Conclusions. Improvement of ED with tadalafil was associated with reduced relationship problems, suggesting that problems were associated with ED and resolved with treatment. Verheyden B, Roumeguère T, Bitton A, Belger M, and Schmitt H. Effects of 12-month tadalafil therapy for erectile dysfunction on couple relationships: Results from the DETECT study. J Sex Med **;**:**[ndash]**. (Source: The Journal of Sexual Medicine) Authors: Abadi AH, Abouel-Ella DA, Ahmed NS, Gary BD, Thaiparambil JT, Tinsley HN, Keeton AB, Piazza GA Two closely related series of novel beta-carboline derivatives, electronically similar to tadalafil (CAS 171596-29-5), were synthesized and evaluated for their inhibitory effects upon phosphodiesterase 5 (PDE5) and phosphodiesterase 11 (PDE11) and their in vitro tumor cell growth inhibitory activity versus HT29 colorectal carcinoma cell line. Interestingly, some of the synthesized compounds showed growth inhibitory properties that appear to be associated with their ability to inhibit PDE5. Moreover, the PDE5 inhibition seems relevant to the stereochemical aspects of the compounds. PMID: 19813465 [PubMed - in process] (Source: Arzneimittel-Forschung) Sildenafil/tadalafil: Sudden sensorineural hearing loss: 2 case reports (Source: Reactions) MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. Authors: Sejima H, Tominaga K, Egawa T, Ikeda M, Shibuya K, Kameyama N, Yamauchi A, Shuto H, Kataoka Y Flushing is one of the most common vasodilation-related adverse effects associated with both nitrates and phosphodiesterase type 5 (PDE5) inhibitors. The present study aimed to investigate the effects of orchidectomy and ovariectomy on isosorbide dinitrate-, sildenafil-, vardenafil- and tadalafil-induced flushing of tail-skin in mice. Both orchidectomy and ovariectomy markedly increased the tail-skin temperature, a good parameter of flushing, induced by isosorbide dinitrate (500mug/kg, i.p.). These observations suggest that both testosterone withdrawal and estrogen withdrawal are risk factors for isosorbide dinitrate-induced flushing. In contrast, sildenafil (100mg/kg, p.o.)-, vardena... How do the variables of age and marital status influence the effectiveness of tadalafil for erectile dysfunction? International Journal of Impotence Research (Source: Medscape Urology Headlines) Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension. Authors: Montani D, Chaumais MC, Savale L, Natali D, Price LC, Jaïs X, Humbert M, Simonneau G, Sitbon O Pulmonary arterial hypertension (PAH) is a rare disease characterized by vascular proliferation and remodeling, resulting in a progressive increase in pulmonary arterial resistance, right heart failure, and death. The pathogenesis of PAH is multifactorial, with endothelial cell dysfunction playing an integral role. This endothelial dysfunction is characterized by an overproduction of vasoconstrictors and proliferative factors, such as endothelin-1, and a reduction of vasodilators and antiproliferative factors, such prostacyclin and nitric oxide. Phosphodiesterase type 5 (PDE-5) is implicated in this process by inactivating cyclic guanosine monophosphate, the nitric oxide pathway... Reliability of efficacy in men with erectile dysfunction treated with tadalafil once daily ... Maimonides Medical Center and Columbia University, New York, NY, USA. (Source: UroToday) Nanoparticles as a Novel Delivery Vehicle for Therapeutics Targeting Erectile Dysfunction Conclusions. Nanoparticles encapsulating three different erectogenic agents resulted in increased erectile function when applied to the penis of a rat model of ED. Nanoparticles represent a potential novel route for topical delivery of erectogenic agents which could improve the safety profile for existing orally administered drugs by avoiding effects of absorption and first-pass metabolism, and would be less hazardous than injection. Han G, Tar M, Kuppam DSR, Friedman A, Melman A, Friedman J, and Davies KP. Nanoparticles as a novel delivery vehicle for therapeutics targeting erectile dysfunction. J Sex Med **;**:**[ndash]**. (Source: The Journal of Sexual Medicine) MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. Topical Erectile Dysfunction Therapy Shows Promise This study was done to evaluate whether the Einstein nanoparticles, which have been shown to penetrate the skin, might allow the targeted delivery of compounds that treat ED and thereby avoid the drugs’ systemic effects. An effective topical therapy could be especially significant for those ED patients – particularly men with diabetes – who have reduced levels of nitric oxide (NO), the signaling molecule that dilates blood vessels responsible for erectile activity. These men, who often aren’t helped by oral PDE5 inhibitor drugs, may benefit from direct application of NO or the PDE5 inhibitors. The nanoparticles were tested on a total of 18 rats bred to have age-related ED. The rats were divided into three treatment groups. One group of seven rats received nanoparticles encapsulat... CONCLUSION: Tadalafil appears to be safe and well tolerated but lacks efficacy in comparison to placebo as a treatment for RP secondary to SSc. PMID: 19755613 [PubMed - as supplied by publisher] (Source: J Rheumatol) Authors: Porst H, Hell-Momeni K, Büttner H Erectile dysfunction (ED) is often associated with increased cardiovascular risk. There is increasing evidence suggesting that dysfunction of the vascular endothelium with reduced bioavailability of nitric oxide (NO) may be the pathogenetic link between ED and cardiovascular disease. The crucial importance of the NO-guanylatecyclase-cGMP-phosphodiesterase pathway for penile erection is mirrored by the efficacy of phosphodiesterase-5 (PDE5) inhibitors in the treatment of ED. In contrast to other currently available PDE5 inhibitors with a half-life time of about 4 h Tadalafil has a half-life time of about 17.5 h resulting in erectile responsiveness for up to 36 h after 1 single dose. Most clinical experience has been reported with on-demand... To determine, by post hoc analysis, the effects of tadalafil (a long-acting phosphodiesterase 5 inhibitor) on peak urinary flow (Qmax), bladder capacity, voiding efficiency and the obstructive symptoms of benign prostatic hyperplasia (BPH) in men with lower urinary tract symptoms secondary to BPH (BPH-LUTS), compared with placebo. After a 4-week placebo run-in period, 1058 men with BPH-LUTS were randomly allocated to receive once daily treatment with placebo or tadalafil (2.5, 5, 10, or 20 mg) for 12 weeks. Uroflowmetry, postvoid residual volume (PVR), and BPH symptom score measurements were assessed throughout the trial. Increases in Qmax were numerically greater for tadalafil (2.5, 5, 10, and 20 mg with percentage changes of 15%, 16%, 17%, 22%, respectively) vs placebo (12%), but did not... Background: The purpose of the study was to evaluate potency following Radical Retropubic Prostatectomy (RRP), in the era of phosphodiesterase (PDE5) inhibitors. Methods: 100 consecutive patients who underwent nerve sparing RRP and were potent preoperatively were analyzed postoperatively for the preservation of erectile function. All operations were performed by the same surgeon using the Walsh technique. The determination of which side to spare, and which to resect, was based on preoperative parameters as well as intraoperative findings. The clinical staging was: cT1=42%, cT2=49% & cT3=9%. Bilateral nerve sparing was performed in 54, unilateral complete & contralateral partial in 3, unilateral in 38, unilateral partial in 1, and non-nerve sparing in 4 patients. The potency scale utilized... MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. Comparing the three PDE-5 inhibitors in the same population Objective: This independent prospective, cross-over, observational and open-label study was undertaken to assess both efficacy, patients’ preference and side-effect profile of Sildenafil, Tadalafil and Vardenafil in the same population. (Source: Journal of Men's Health) Patient Money: For Common Male Problem, Hope Beyond a Pill For some, pills like Viagra and Cialis don’t work. And even if they do, there are more cost-effective ways to treat a problem that grows more common with age. (Source: NYT > Health) To evaluate factors that affect compliance in men who enrol in a phosphodiesterase type 5 inhibitor (PDE5I) protocol after nerve-sparing robot-assisted prostatectomy (RAP), and report on short-term outcomes, as PDE5Is may help restore erectile function after RAP and patient adherence to the regimen is a factor that potentially can affect outcome. We prospectively followed 77 men who had nerve-sparing RAP and enrolled in a postoperative penile rehabilitation protocol. The men received either sildenafil citrate or tadalafil three times weekly. The minimum follow-up was 8 weeks. Potency was defined as erection adequate for penetration and complete intercourse. Compliance was defined as men adhering to the regimen for [ge]2 months. The mean age of the cohort was 57.8 years and the median follo... Audience: Consumers, pharmacists [UPDATED 08/24/2009] Nutracoastal has found by lab analysis that Lot 90260 contains Tadalafil, an active ingredient of an FDA-approved drug for erectile dysfunction, making Steam an unapproved drug. The lot number... (Source: Drugs.com - FDA MedWatch Alerts) Link Between Erectile Dysfunction And Obesity Explored in Obesity and Weight Management August 24, 2009 (EurekAlert) - Obese men are at increased risk for erectile dysfunction (ED), likely caused by atherosclerosis-related hypertension and cardiovascular disease, as well as hormonal changes associated with obesity, as described in a timely article published in Obesity and Weight Management, a journalzine published by Mary Ann Liebert, Incorporated. As many as 30-40% of men over the age of 50 may experience ED, and both obesity and physical inactivity may increase their risk. The build-up of atherosclerotic plaque in the arteries of obese men can damage the arterial lining and contribute to elevated blood pressure. In addition to atherosclerosis, the hormonal changes that accompany obesity, including lower testosterone, increase the risk of ED. The modifiable risk factors ... MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. Link Between Erectile Dysfunction And Obesity Explored in Obesity and Weight Management August 24, 2009 (EurekAlert) - Obese men are at increased risk for erectile dysfunction (ED), likely caused by atherosclerosis-related hypertension and cardiovascular disease, as well as hormonal changes associated with obesity, as described in a timely article published in Obesity and Weight Management, a journalzine published by Mary Ann Liebert, Incorporated. As many as 30-40% of men over the age of 50 may experience ED, and both obesity and physical inactivity may increase their risk. The build-up of atherosclerotic plaque in the arteries of obese men can damage the arterial lining and contribute to elevated blood pressure. In addition to atherosclerosis, the hormonal changes that accompany obesity, including lower testosterone, increase the risk of ED. The modifiable risk factors ... In conclusion sildenafil, vardenafil and tadalafil show similar efficacy in the clinical practice. However, patients receiving tadalafil display a lower risk to discontinue or change the treatment.Asian Journal of Andrology advance online publication. 24 Augest 2009; doi: 10.1038/aja.2009.48. PMID: 19701217 [PubMed - as supplied by publisher] (Source: Asian Journal of Andrology) Conclusion: We have shown that curcumin acts on localized prostate cancer to induce apoptosis and may therefore be an option as a future therapeutic agent. (Source: International Braz J Urol) Effect of Tadalafil on prostate haemodynamics: preliminary evaluation with contrast-enhanced US Conclusions In patients with BPH, vascular changes are observed in the prostate after Tadalafil administration, which can be detected with CEUS. Content Type Journal ArticleCategory Uro-Genital Radiology/Radiologia Uro-GenitaleDOI 10.1007/s11547-009-0449-8Authors M. Bertolotto, Università di Trieste, Ospedale di Cattinara UCO di Radiologia Strada di Fiume 449 34149 Trieste ItalyE. Trincia, Università di Trieste, Ospedale di Cattinara UCO di Radiologia Strada di Fiume 449 34149 Trieste ItalyR. Zappetti, Università di Trieste, Ospedale di Cattinara UCO di Radiologia Strada di Fiume 449 34149 Trieste ItalyR. Bernich, Università di Trieste, Ospedale di Cattinara UCO di Radiologia Strada di Fiume 449 34149 Trieste ItalyG. Savoca, Ospedale Fondazione San Raffaele Giglio,... PDE-5 Inhibitors May Be Useful for Benign Prostatic Hyperplasia The biologic effects of phosphodiesterase-5 inhibitors (PDE5-Is), such as sildenafil and tadalafil, may make them useful agents for treating lower urinary tract symptoms caused by benign prostatic hyperplasia (BPH), Belgian researchers report in the August issue of BJU International. However, much research remains to be done. Reuters Health Information (Source: Medscape Medical News Headlines) MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. CIALIS (Tadalafil) Tablet, Film Coated [Eli Lilly And Company] Updated Date: Aug 13, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)) Conclusions. The results suggest that PDE5i may increase sexual arousal by acting in the central nervous system. This effect may be mediated (at least in part) by the activation of mesolimbic dopaminergic neurons. Sanna F, Succu S, Boi A, Melis MR, and Argiolas A. Phosphodiesterase type 5 inhibitors facilitate noncontact erections in male rats: Site of action in the brain and mechanism of action. J Sex Med **;**:**[ndash]**. (Source: The Journal of Sexual Medicine) Conclusion. Men with a history of established sildenafil citrate use alter their dose-attempt behavior when treated with tadalafil irrespective of geography. However, the extent to which sexual behavior alters is not uniform across geographical regions, suggesting that dosing instructions and duration of drug effectiveness, in combination with personal and cultural preferences, may determine sexual behavior with PDE5 inhibitor use. Rubio-Aurioles E, Glina S, Abdo CHN, Hernandez-Serrano R, Rampazzo C, Sotomayor M, West TM, Gallagher GL, and Lenero E. Timing of dose relative to sexual intercourse attempt in previous sildenafil citrate users treated with tadalafil: A geographical comparison from a single arm, open-label study. J Sex Med **;**:**[ndash]**. (Source: The Journal of Sexual Medici... Effect of Tadalafil on Renal Resistivity and Pulsatility Index in Partial Ureteral Obstruction Urol Int 2009;83:75-79 (DOI:10.1159/000224873) (Source: Karger Publishers) Source: DARE Area: Evidence > Drug Class Focused Reviews CRD Summary: This review of the efficacy of sildenafil, tadalafil and vardenafil for the treatment of erectile dysfunction concluded that all three drugs are highly effective; no differences were identified between them. The authors thoroughly investigated possible sources of bias in the review; their conclusions were in line with the evidence presented and likely to be reliable. CRD Commentary: This review had clear inclusion criteria for participants, interventions and study designs. Inclusion criteria for outcomes were broad, but this appeared unlikely to have affected study selection or the findings of the review. The authors searched a wide range of sources without restrictions by language or publication status. Validity was ... MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. Opteron 1 Inc. dba Nature & Health Co., announced today that it is conducting a voluntary nationwide recall of the company's five supplement products sold under the following names: LibieXtreme, Y-4ever, Libimax X Liquid, Powermania Liquid and Capsule, Herbal Disiac. The Company has been informed by representatives of the Food and Drug Administration (FDA) that lab analysis by FDA of these five samples found they contains either tadalafil, an active ingredient of an FDA-approved drug for erectile dysfunction (ED) , its analog aminotadalafil, or the analog of sidenafil, an active ingredient of another FDA-approved ED drug, making these products unapproved drugs. (Source: Food and Drug Administration) UroToday.com - Men with benign prostatic hyperplasia (BPH) often suffer from lower urinary tract symptoms (LUTS; BPH-LUTS) such as urinary frequency, urgency, intermittency, nocturia, straining, incomplete emptying, or weak urinary stream... (Source: Erectile Dysfunction / Premature Ejaculation News From Medical News Today) UroToday.com - Men with benign prostatic hyperplasia (BPH) often suffer from lower urinary tract symptoms (LUTS; BPH-LUTS) such as urinary frequency, urgency, intermittency, nocturia, straining, incomplete emptying, or weak urinary stream. (Source: Health News from Medical News Today) Authors: R Shabsigh, C Donatucci, R Costabile, M A Perelman, P Burns, H Zeigler & D G Wong (Source: International Journal of Impotence Research) Authors: R Shabsigh, C Donatucci, R Costabile, M A Perelman, P Burns, H Zeigler & D G Wong (Source: International Journal of Impotence Research) MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. New indication: Tadalafil (Adcirca), a phosphodiesterase type 5 inhibitor, was approved on May 22, 2009, for the treatment of pulmonary arterial hypertension (WHO Group I) (Source: Modern Medicine) Beyond the Abstract - Effects of Once-Daily Tadalafil on Erectile Function in Men with ... BERKELEY, CA (UroToday.com) - Men with benign prostatic... (Source: UroToday) The ability of pharmacological preconditioning mimetics to confer long-lasting and sustained cardioprotection may be a logical criterion to develop a drug that can be used clinically for cardioprotection. We propose here that the use of long-acting phosphodiesterase-5 inhibitor, tadalafil, may confer sustained cardioprotection against ischemia. Tadalafil (5 mg/kg) was administered orally to male C57B/6J mice (n = 6 in each treatment subgroup at each time point studied). Hearts were isolated and subjected to 40 min of ischemia and 30 min of reperfusion on Langendorff's apparatus at 1, 12, 24, 36, 48, 60, 72, and 108 h after tadalafil administration. In 1- to 48-h subgroups, tadalafil was given once at 0 h only. In 60- and 72-h subgroups, tadalafil was given twice at 0 and 36 h. Similarly, i... Conclusions. An overall equivalence was demonstrated in the subjective perception of treatment benefits for all the PDE5i tested. However, sildenafil, in a dose-dependent manner, was the unique PDE5i able to ameliorate some of the penile flow parameters within the 8-week treatment period. These findings should be interpreted conservatively because of the observational nature of the study. Jannini EA, Isidori AM, Gravina GL, Aversa A, Balercia G, Bocchio M, Boscaro M, Carani C, Corona G, Fabbri A, Foresta C, Forti G, Francavilla S, Granata ARM, Maggi M, Mansani R, Palego P, Spera G, Vetri M, and Lenzi A on behalf of the Endotrial Study Group. The ENDOTRIAL study: A spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in t... CIALIS (Tadalafil) Tablet, Film Coated [Eli Lilly And Company] Updated Date: Jun 25, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)) MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. Improvements in confidence, sexual relationship and satisfaction measures: results of a randomized trial of tadalafil 5 mg taken once daily International Journal of Impotence Research advance online publication, June 18, 2009. doi:10.1038/ijir.2009.22 Authors: A D Seftel, J Buvat, S E Althof, J G McMurray, H L Zeigler, P R Burns & D G Wong (Source: International Journal of Impotence Research) Authors: R Shabsigh, G A Broderick, S Althof, F Natanegara & D G Wong (Source: International Journal of Impotence Research) Adcirca (Tadalafil Tablets) - new on RxList Adcirca (Tadalafil Tablets) drug description - FDA approved labeling for prescription drugs and medications at RxList (Source: RxList - New and Updated Drug Monographs) Conclusion. Corticosteroids, but not phodphodiesterase-5 inhibition, partially prevented the limitation of exercise capacity in subjects with intense hypoxic pulmonary vasoconstriction at high altitude. PMID: 19520908 [PubMed - as supplied by publisher] (Source: American Journal of Respiratory and Critical Care Medicine) United Therapeutics Corporation (Nasdaq: UTHR) and Eli Lilly and Company (NYSE: LLY) today announced the results of a pivotal 16-week study showing that a once-daily dose of tadalafil was generally well tolerated, improved exercise capacity and improved time to clinical worsening in patients with pulmonary arterial hypertension (PAH)(1). (Source: Health News from Medical News Today) MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. BPH-related symptoms improve with PDE-5 inhibitor Findings from a multicenter, randomized, double-blind, placebo-controlled study are consistent with previously reported data showing that tadalafil (Cialis) improves lower urinary tract symptoms associated with BPH. (Source: UrologyTimes - BPH) Data Findings Published in June Issue of Circulation SILVER SPRING, Md. and INDIANAPOLIS, June 9 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (NASDAQ:UTHR) and Eli Lilly and Company (NYSE:LLY) today announced the results of a pivotal... (Source: Drugs.com - Clinical Trials) Clinical Trial Summary: Pulmonary Arterial Hypertension and Response to Tadalafil (PHIRST) Sildenafil has been shown to be beneficial in patients with pulmonary arterial hypertension (PAH) in improving exercise capacity and hemodynamic parameters. However, there are no trials studying the role of sildenafil or other similar phosphodiesterase type-5 (PDE-5) inhibitors in patients with PAH . . . (Source: Cardiosource) Tadalafil improves partner QOL too (Source: PharmacoEconomics and Outcomes News) New Use for Active Ingredient of Cialis Title: New Use for Active Ingredient of CialisCategory: Health NewsCreated: 6/1/2009Last Editorial Review: 6/1/2009 (Source: MedicineNet High Blood Pressure General) MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. New Use for Active Ingredient of Cialis (Source: eMedicineHealth.com) New Use for Active Ingredient of Cialis Title: New Use for Active Ingredient of CialisCategory: Health NewsCreated: 6/1/2009Last Editorial Review: 6/1/2009 (Source: MedicineNet Lungs General) From nature to drug discovery: the indole scaffold as a 'privileged structure'. Authors: de Sá Alves FR, Barreiro EJ, Fraga CA The indole scaffold probably represents one of the most important structural subunits for the discovery of new drug candidates. The demonstration that many alkaloids contain the indole nucleus, the recognition of the importance of essential amino acid tryptophan in human nutrition and the discovery of plant hormones served to bring about a massive search on indole chemistry, giving rise to a vast number of biologically active natural and synthetic products, with a wide range of therapeutic targets, such as anti-inflammatories, phosphodiesterase inhibitors, 5-hydroxytryptamine receptor agonists and antagonists, cannabinoid receptors agonists and HMG-CoA reductase inhibitors. Many of these target-receptors belong to the class of GPCRs (... Tadalafil (Cialis) In The Treatment Of Erectile Dysfunction UroToday.com - This updated review of tadalafil (Cialis), one of the three available phosphodiesterase type 5 (PDE5) inhibitors that revolutionized the treatment of erectile dysfunction (ED), analyzes its latest clinical studies. Tadalafil's most unique and identifying characteristic is its long half-life of 17.5 hours, compared with 4 hours for sildenafil (Viagra) and vardenafil (Levitra)... (Source: Erectile Dysfunction / Premature Ejaculation News From Medical News Today) Tadalafil (Cialis) In The Treatment Of Erectile Dysfunction UroToday.com - This updated review of tadalafil (Cialis), one of the three available phosphodiesterase type 5 (PDE5) inhibitors that revolutionized the treatment of erectile dysfunction (ED), analyzes its latest clinical studies. Tadalafil's most unique and identifying characteristic is its long half-life of 17.5 hours, compared with 4 hours for sildenafil (Viagra) and vardenafil (Levitra). (Source: Health News from Medical News Today) MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. Tadalafil improves partner QOL too. Page: 13 (Source: PharmacoEconomics & Outcomes News) PHIRST Published; Tadalafil Approved for PAH Tadalafil is a phosphodiesterase type-5 inhibitor and is now available in the 40-mg dose for the purpose of increasing exercise capacity in patients with WHO class 1 pulmonary arterial hypertension. Heartwire (Source: Medscape Medical News Headlines) FDA Approves ADCIRCA™ (Tadalafil) Tablets for the Treatment of Pulmonary Arterial ... SILVER SPRING, MD, USA (Press Release) - May 26, 2009 (Source: UroToday) PHIRST published, and tadalafil approved for pulmonary arterial hypertension Tadalafil is a phosphodiesterase type-5 inhibitor and is now available in the 40-mg dose for the purpose of increasing exercise capacity in patients with WHO class 1 PAH. (Source: theHeart.org) FDA Approves ADCIRCA(TM) (Tadalafil) Tablets For The Treatment Of Pulmonary Arterial Hypertension United Therapeutics Corporation (Nasdaq: UTHR) announced that the United States Food and Drug Administration (FDA) has approved ADCIRCA(TM) (tadalafil) tablets for oral administration, with a recommended dose of 40 mg, as the first once-daily phosphodiesterase type 5 (PDE5) inhibitor for the treatment of pulmonary arterial hypertension (PAH). (Source: Health News from Medical News Today) MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. FDA Approves Adcirca (tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension SILVER SPRING, Md., May 26 /PRNewswire-FirstCall/ -- United Therapeutics Corporation announced today that the United States Food and Drug Administration (FDA) has approved Adcirca (tadalafil) tablets for oral administration, with a recommended dose... (Source: Drugs.com - New Drug Approvals) FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension Conference Call to be Held at 9:00 a.m. Eastern Time Today, May 26, 2009 SILVER SPRING, Md., May 26 (HSMN NewsFeed) -- United Therapeutics Corporation (Nasdaq: UTHR ) announced today that the United States Food and Drug Administration (FDA) has approv... Biopharmaceuticals, FDAUnited Therapeutics, ADCIRCA, tadalafil, pulmonary arterial hypertension (Source: HSMN NewsFeed) Evidence Grows For Multiple Drug Therapy Use With Tracleer(R) (bosentan) As First Line Therapy Patients with pulmonary arterial hypertension (PAH) who receive an additional 20 or 40mg tadalafil to their first-line bosentan therapy demonstrated a trend towards a positive 23m improvement during the six-minute walk distance (6MWD) test, a measure of symptom severity and functioning, according to the PHIRST study data [1] presented at the 2009 American Thoracic Society (ATS) conference today. (Source: Health News from Medical News Today) ATS bosentan in combination with tadalafil <p>Evidence grows for multiple drug therapy use with Tracleer® (bosentan) as first line therapy</p> <p>ALLSCHWIL, SWITZERLAND – 18 May 2009 – Patients with pulmonary arterial hypertension (PAH) who... (Source: Drugs.com - Clinical Trials) No Abstract. (Source: Practical Diabetes International) MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. Eli Lilly and Company (NYSE: LLY) announced results from a double-blind, placebo-controlled study which showed that tadalafil 5 mg dose taken once daily was generally well-tolerated, improved erectile function for men with erectile dysfunction (ED) and reported improvement in the sexual quality of life scores for men and their female partners. (Source: Health News from Medical News Today) INDIANAPOLIS, May 06, 2009 /PRNewswire-FirstCall/ -- Eli Lilly and Company today announced results from a double-blind, placebo-controlled study which showed that tadalafil 5 mg dose taken once daily was generally well-tolerated, improved erectile... (Source: Drugs.com - Clinical Trials) Could Cialis help treat some cancers that it also might make more likely? We all know what Cialis (tadalafil) does for the phallus, but what if it fought cancer? A team from Johns Hopkins University School of Medicine just started enrolling patients in a clinical trial on Cialis for treating head and neck cancer. [More] (Source: Scientific American - Official RSS Feed) AUA 2009: Tadalafil Effective for Urinary Symptoms of Prostatic Hypertrophy Phosphodiesterase enzyme 5 (PDE5) inhibitor tadalafil improves bladder outlet obstruction symptoms of benign prostatic hypertrophy (BPH). Medscape Medical News (Source: Medscape Medical News Headlines) Tadalafil shows improvement in LUTS; benefit unexplained by urodynamic effects Findings from a multicenter, double-blind, placebo-controlled study are consistent with previously reported data showing that tadalafil (Cialis) improves lower urinary tract symptoms associated with BPH. However, the benefit cannot be explained by effects on pressure-flow urodynamics. (Source: Modern Medicine) MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. Recall of dietary supplement due to undeclared drug tadalafil, which may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may lower blood pressure to dangerous levels. (Source: FDA MedWatch) The recalled Libimax is sold as a 1 capsule individual pack or 10-capsule and 20-capsule plastic bottles in retail stores in California, Georgia, Illinois, Texas, and Ohio. The product label neither states it contains tadalafil nor warns consumers with high blood pressure not to ingest the product. (Source: Food and Drug Administration) Audience: Consumers, pharmacists Nature & Health Co. and FDA notified healthcare professionals of a recall of a supplement product, Libimax. FDA analysis found the product contains tadalafil, an active ingredient of an FDA-approved drug for... (Source: Drugs.com - FDA MedWatch Alerts) Tune in now to hear Dr. Anton Bueschen: Issues facing AUA membership; Dr. Joel Slaton: Androgen ablation in metastatic PCa; Dr. Elizabeth Mueller: Fluid management and urge incontinence; and Dr. Stephen Kraus: Effects of tadalafil in BPH. (Source: Modern Medicine) Safety, Efficacy, and Pharmacokinetic Overview of Low-Dose Daily Administration of Tadalafil Conclusions. Consistent with pharmacokinetic predictions, data from clinical trials indicate that once-daily use of low-dose tadalafil is a safe and effective treatment for men with ED. Wrishko R, Sorsaburu S, Wong D, Strawbridge A, and McGill J. Safety, efficacy, and pharmacokinetic overview of low-dose daily administration of tadalafil. J Sex Med **;**:**[ndash]**. (Source: The Journal of Sexual Medicine) MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. Tadalafil May Effectively Treat Symptoms of BPH-LUTS in Addition to Erectile Dysfunction LINTHICUM, Md., April 27 /PRNewswire-USNewswire/ -- Tadalafil may improve lower urinary tract symptoms in men with benign prostatic hyperplasia (BPH). Researchers from Nashville, Dallas, San Antonio and Indianapolis will present these findings... (Source: Drugs.com - Clinical Trials) Tadalafil May Effectively Treat Symptoms Of BPH-LUTS In Addition To Erectile Dysfunction Tadalafil may improve lower urinary tract symptoms in men with benign prostatic hyperplasia (BPH). Researchers from Nashville, Dallas, San Antonia and Indianapolis presented these findings during the 104th Annual Scientific Meeting of the American Urological Association (AUA). (Source: Urology / Nephrology News From Medical News Today) Tadalafil may effectively treat symptoms of BPH-LUTS in addition to erectile dysfunction (American Urological Association) Tadalafil may improve lower urinary tract symptoms in men with benign prostatic hyperplasia. Researchers from Nashville, Dallas, San Antonia and Indianapolis will present these findings during the 104th Annual Scientific Meeting of the American Urological Association. (Source: EurekAlert! - Social and Behavioral Science) Conclusions: Our experimental model demonstrates that oral donor pretreatment with a long-acting phosphodiesterase inhibitor is an effective strategy for improving pulmonary performance after reperfusion. Importantly, phosphodiesterase enzymes and their downstream effectors may play a critical role in reperfusion injury after lung transplantation. (Source: The Journal of Thoracic and Cardiovascular Surgery) Tadalafil or Sildenafil Not Linked to Visual Effects With 6 Months of Daily Use In a randomized trial of medications for erectile dysfunction, no abnormalities in electroretinography or visual function and no treatment-related findings suggestive of drug toxicity were observed. Medscape Medical News (Source: Medscape FamilyMedicine Headlines) MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. Authors: Guo YL, Viswanathan VP, Chiang HS, Choi HK, Yip AW, Shen W, Kopernicky V We evaluated the efficacy and safety of as-needed tadalafil in a diverse clinical population (with varying patient demographics, disease severity, and comorbid medical conditions) of Asian men with erectile dysfunction (ED). An integrated analysis of five double-blind, placebo-controlled trials (N = 1 046) was performed. Patients were randomly assigned to receive 10 mg tadalafil (N = 185), 20 mg tadalafil (N = 510), or placebo (N = 351). Efficacy assessments included the International Index of Erectile Function (IIEF), Sexual Encounter Profile (SEP) diary and Global Assessment Question (GAQ). Patients receiving 10 mg or 20 mg tadalafil showed significant improvement from baseline-to-end point on the IIEF-... Study: Impotence drugs don't harm men's vision The erectile dysfunction drugs Cialis (tadalafil) and Viagra (sildenafil) didn't appear to damage vision in men who took the ... (Source: USATODAY.com Health) Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although surveyed primary care physicians (PCPs) are generally satisfied with the efficacy of available phosphodiesterase type 5 (PDE5) inhibitors such as Pfizer's Viagra, Eli Lilly's Cialis and Bayer Healthcare/Schering-Plough/GlaxoSmithKline's Levitra, they are less satisfied with the efficacy of this drug class in difficult-to-treat patient subpopulations. (Source: Erectile Dysfunction / Premature Ejaculation News From Medical News Today) Conclusions: Our findings have shown that sildenafil, vardenafil, and tadalafil relax HCC tissues in a concentration-dependent manner, but the maximal relaxation obtained with tadalafil was significantly lower than that obtained with sildenafil and vardenafil. Moreover, the PDE-5 inhibitors interacted with endogenous and exogenous NO, amplifying its HCC relaxation. (Source: Urology) Viagra, Cialis appear to not harm vision INDIANAPOLIS, April 14 (UPI) -- Two medications used to treat erectile dysfunction do not appear to damage vision when taken daily for six months, U.S. researchers said. (Source: Health News - UPI.com) MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. Erectile Dysfunction Treatments Do Not Appear to Damage Vision Over Six Months CHICAGO, April 13, 2009—Two medications used to treat erectile dysfunction in men (tadalafil and sildenafil) do not appear to have visual side effects when taken daily for six months, despite concerns about eye-related complications, according... (Source: Drugs.com - Clinical Trials) Do Viagra, Cialis Damage Vision? Some have worried that Viagra and Cialis, which treat erectile dysfunction, can also hurt the eyes. Researchers test the theory. (Source: WDSU.com - Health) Study: No Vision Loss From ED Drugs Using erectile dysfunction (ED) drugs like Viagra and Cialis for six months shouldn't lead to vision loss, according to a new study. (Source: WebMD Health) Healthy men who took Viagra, Cialis see fine: study CHICAGO (Reuters) - Healthy men who took Cialis or Viagra daily for six months did not develop any significant vision problems, U.S. researchers said on Monday in a company-funded study aimed at addressing concerns about the popular impotence treatments. (Source: Reuters: Health) CLINICAL TRIAL: Retinal Effects of 6 Months of Daily Use of Tadalafil or Sildenafil Conclusions No abnormalities in ERG or visual function and no treatment-related findings suggestive of drug toxicity are associated with daily administration of tadalafil or sildenafil for 6 months. Application to Clinical Practice Assessed visual safety of tadalafil/sildenafil administered daily over a prolonged period. Trial Registration clinicaltrials.gov Identifier: NCT00333281 (Source: Archives of Opthalmology) MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. CONCLUSION: Despite the fact that inhibitors of PDE1, PDE4, and PDE5 exerted only a weak relaxant response on detrusor strips precontracted by carbachol, our findings indicate that both the cAMP and cGMP pathways might be involved in the relaxation mechanism of human detrusor smooth muscle. PMID: 19352616 [PubMed - as supplied by publisher] (Source: Der Urologe. Ausg. A) Cialis, Cymbalta Lead 2008’s Most Recalled Drug Ads NEW YORK, March 31, 2009--Eli Lilly produced three of the top four most-recalled prescription drug and vaccine ads on TV last year, according to new research released today by The Nielsen Company. The ranking revealed that a spot for... (Source: Drugs.com - Pharma News) Oxygen is a potent cerebral vasoconstrictor, but excessive exposure to hyperbaric oxygen (HBO2) can reverse this vasoconstriction by stimulating brain nitric oxide (NO) production, which increases cerebral blood flow (CBF)—a predictor of O2 convulsions. We tested the hypothesis that phosphodiesterase (PDE)-5 blockers, specifically sildenafil and tadalafil, increase CBF in HBO2 and accelerate seizure development. To estimate changes in cerebrovascular responses to hyperoxia, CBF was measured by hydrogen clearance in anesthetized rats, either control animals or those pretreated with one of these blockers, with the NO inhibitor N-nitro-l-arginine methyl ester (l-NAME), with the NO donor S-nitroso-N-acetylpenicillamine (SNAP), or with a blocker combined with l-NAME. Animals were exposed ... Men Who Fake Orgasms- Part II (A.K.A the danger of shear forces) Fred was a big, hulking 62 year old contractor with a salty sense of humor who had been my patient for many years. On his most recent visit when I examined him, his penis was black and blue, and there were several small tears of the skin on the shaft. "What happened?" I asked? "It looks bad, doesn't it?" he said with a grin. "This is Nature's way of demonstrating the laws of physics. We're talking about shear forces here, doc." "What are you talking about?" I asked. "Immovable object meets irresistible force," he went on. "Except that the coverage of the irresistible force is only a thin layer of delicate skin." Fred has diabetes, and due to poor nerve function, he also has trouble having an orgasm. Diabetes is also a major risk factor for erectile dysfunction (ED), and this had been... (Source: The Journal of Sexual Medicine) MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. Conclusions. Tadalafil 5 mg once daily significantly improved EF and sexual quality of life for men with ED. In addition, the sexual quality of life of the female partners of the men treated with tadalafil was significantly improved. Rubio-Aurioles E, Kim ED, Rosen RC, Porst H, Burns P, Zeigler H, and Wong DG. Impact on erectile function and sexual quality of life of couples: a double-blind, randomized, placebo-controlled trial of tadalafil taken once daily. J Sex Med **;**:**[ndash]**. (Source: The Journal of Sexual Medicine) Conclusions: Our results have provide additional evidence that the function of prostatic smooth muscle is under the control of peptidergic and cyclic nucleotide (cyclic guanosine monophosphate, cyclic adenosine monophosphate)-mediated pathways. This might give a rationale for the use of drugs interacting with cyclic guanosine monophosphate or cyclic adenosine monophosphate signaling, such as PDE inhibitors or nitric oxide donors, in the pharmacotherapy of the benign prostatic syndrome. (Source: Urology) CONCLUSIONS: Our results have provide additional evidence that the function of prostatic smooth muscle is under the control of peptidergic and cyclic nucleotide (cyclic guanosine monophosphate, cyclic adenosine monophosphate)-mediated pathways. This might give a rationale for the use of drugs interacting with cyclic guanosine monophosphate or cyclic adenosine monophosphate signaling, such as PDE inhibitors or nitric oxide donors, in the pharmacotherapy of the benign prostatic syndrome. PMID: 19285714 [PubMed - as supplied by publisher] (Source: Urology) Sildenafil/tadalafil/vardenafil: First report of rosacea: 10 case reports (Source: Reactions) Sildenafil/tadalafil/vardenafil: First report of rosacea: 10 case reports. Page: 41 (Source: Reactions Weekly) MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. Likelihood of Tadalafil-Associated Adverse Events in Integrated Multiclinical Trial Database: ... Department of Surgery, Division of Urology, St. Joseph's Health Care London, University of Western Ontario, London, Ontario, Canada. (Source: UroToday) Is it really men who stop couple sexuality? The word on the street is that male sexual desire is automatic, erections are spontaneous, and intercourse frequent. Another assumption is that men are easily frustrated by women's inhibited desire and their difficulty to reach orgasm. And, with the introduction of pro-erection medications (Viagra, Cialis, Levitra) erectile dysfunction has been cured and the man returns to the easy, predictable, and autonomous erections of youth. How true are these assumptions? The majority of men learn to be sexual with spontaneous erections, a sense of sexual lust and control, and highly predictable sexual intercourse. For most men under 30, sexual response is autonomous-he can experience desire, arousal, and orgasm and need nothing from his partner. The traditional model of total predictability and cont... Preoperative administration of PDE-5 Inhibitors We applaud McAllister et al for posing the very pertinent question, “Are guidelines needed for the perioperative discontinuation of phosphodiesterase type 5 [PDE-5] inhibitors?” and suggesting an answer, “To avoid confusion, perhaps adoption of the previously recommended one week off of all PDE-5 inhibitors before elective surgery would be wisest.” However, in some patients withholding PDE-5 inhibitors may be life-threatening. Sildenafil is not only marketed as Viagra (blue diamond-shaped tablet) for erectile dysfunction (ED) but also as Revatio (white round tablet) for the treatment of pulmonary arterial hypertension (PAH). Erectile dysfunction and chronic obstructive pulmonary disease (COPD) coexist in our older patient population. A subset of patients with COPD have PAH , especi... Illegal Sex Drug Contamination Sex addicts beware!! If you have been using illegal anti-impotence drugs and herbs, including counterfeit Cialis, or herbal preparations such as Power 1 Walnut or Santi Bovine Penis Erecting Capsule, you... (Source: About.com Addictions) Fake Cialis linked to dangerously low blood sugar An unusual outbreak of dangerously low blood sugar has been traced to illegal anti-impotence drugs and herbal remedies contaminated with a drug for diabetics, doctors warn. (Source: CBC | Health) MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. Cavernous Neurotomy in the Rat is Associated with the Onset of an Overt Condition of Hypogonadism Conclusion. BCN was associated with hypogonadism, probably of central origin. T supplementation in hypogonadal BCN rats ameliorates some aspects of BCN-induced ED, including collagenization of penile smooth muscle and endothelial dysfunction, except surgically induced altered nNOS expression.Vignozzi L, Filippi S, Morelli A, Marini M, Chavalmane A, Fibbi B, Silvestrini E, Mancina R, Carini M, Vannelli GB, Forti G, and Maggi M. Cavernous neurotomy in the rat is associated with the onset of an overt condition of hypogonadism. J Sex Med **;**:**[ndash]**. (Source: The Journal of Sexual Medicine) Ten Years of Phosphodiesterase Type 5 Inhibitors in Spinal Cord Injured Patients Conclusions. Literature suggests that all oral PDE5 inhibitors represent a safe and effective treatment option for ED caused by SCI. Further research is needed on head-to-head comparative trials and SCI patient preference for these drugs; their impact on ejaculation and orgasm function, their early use after SCI for increasing the recovery rate of a spontaneous erection, and their effectiveness and tolerability in the long-term are still to be investigated. Lombardi G, Macchiarella A, Cecconi F, and Del Popolo G. Ten years of phosphodiesterase type 5 inhibitors in spinal cord injured patients. J Sex Med **;**:**[ndash]**. (Source: The Journal of Sexual Medicine) Is there any likely interaction between GTN ointment and sildenafil administration The ATTRACT service is based in Wales, and performs pragmatic reviews of the evidence-base for questions suggested by clinicians within the UK. The following answer is given to this question: Answer: The summary of product characteristics (SPC) for Rectogesic (1) the glyceryl trinitrate ointment for treatment of anal fissure found in the BNF notes under contraindications: “Concomitant treatment with sildenafil citrate, tadalafil, vardenafil and with nitric oxide (NO) donors, such as other long-acting GTN products, isosorbide dinitrate and amyl or butyl-nitrite.” Further in the SPC they note under interactions with other medicines: “The hypotensive effect of nitrates are potentiated by concurrent administration of phosphodiesterase inhibitors, e.g. sildenafil, tadalafil and vard... Once-A-Day Pill For Impotence, UK UK men with impotence now have access to a daily tablet to treat their condition all day, every day. The new pill, Cialis® (tadalafil), Once-A-Day, is the first oral impotence treatment which is designed to enable couples to initiate sex whenever they wish. (Source: Health News from Medical News Today) Phosphodiesterase 5 Inhibition Improves Beta Cell Function in the Metabolic Syndrome. Conclusions: Phosphodiesterase 5 inhibition may represent a novel strategy for improving beta cell function in metabolic syndrome. PMID: 19196886 [PubMed - as supplied by publisher] (Source: Diabetes Care) MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources. Once-a-day erectile dysfunction pill launched GPs can now prescribe the erectile dysfunction drug tadalafil in a form of a once-daily pill, which its manufacturers claim will transform the lives of patients. (Source: Pulse Today Clinical Updates) CONCLUSIONS: The findings from classification and regression tree analyses could help physicians to better understand some of the associations between patient characteristics and the tolerability of phosphodiesterase type 5 inhibitors and could contribute to improved patient outcomes, satisfaction, treatment seeking, and treatment persistence. PMID: 19193420 [PubMed - as supplied by publisher] (Source: Urology) Tadalafil: Quadrantanopia: case report (Source: Reactions) Authors: Hasegawa T, Takahashi K, Saijo M, Ishii T, Nagata T, Kurihara M, Haishima Y, Goda Y, Kawahara N A new sildenafil analogue, cyclopentynafil (1) and a new tadalafil analogue, N-octylnortadalafil (2) were isolated from a dietary supplement illegally marketed for erectile dysfunction. The structures of the sildenafil and tadalafil analogues were elucidated by using HPLC-photodiode array (PDA), LC-MS, high-resolution MS, NMR and circular dichroism (CD). These compounds were determined to be 5-[2-ethoxy-5-(4-cyclopentylpiperazin-1-ylsulfonyl)phenyl]-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one and (6R,12aR)-2-octyl-6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione, respectively. Recently, a large number of phosphodie... |
Top Viagra StoreA first shop in the series of one-pill shops is rightfully viagra-targeted. The index page offers only Viagra, both generic and original.It is possible to purchase other ED products from other pagers, but the main accent is on Viagra. Indian MedsA most recent indian-themed, ethnic site. Includes generic and original (brand) products. al our standard navigational tools and support options are available. This site converts nicely on general pharmaceutical traffic as it has products for vurtually any need. Friendly ED PharmacyMany ED customers are anxious about the status their orders. This special friendly site is here to solve the problem. "State of the art" design features high usability and clearly visible support options. All this helps to satisfy even the most demanding customer and results in increased sales ratio. Popular ED ProductsThis ED site offers simplistic design that gets right to the point - this IS the site for ED. Popular ED list the top selling products and converts best on ED-targeted, pill-specific traffic. Perfect ED StoreThis site is just right for ED customers. All ED products are conveniently listed at main page, allowing to make an easy choice. Our regular Sample Pills Offer is emphasized here. Customers can try new products and are likely to return for more refills. Worlds Best PharmacyThe name says it all. This is the best online pharmacy on the web. The index page is set to show the most polular ED products, while the menu and quicksearch allow to find products in other categories. Delhi DrugsThis Indian-themed site offers a completely new design. All our generic products are availabe and can easily be located with the help of quicksearch feature. Includes our latest shopping engine and billing page. Indian GenericsMany customers are looking for Indian drugs, and this site is designed specifically for such customers. It includes many generic products, modern design, translated into 7 languages and prices in both USD and Euros. Also it uses our latest shopping engine and billing page. |
All rights reserved.